相关实验视频
Updated: Jun 17, 2026

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
在785名患有原发性高胆固醇血清症的患者中,瑞瓦斯塔丁对C反应性蛋白的快速降低
P M Ridker1, N Rifai, S P Lowenthal
1Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, MA 02115, USA. pridker@partners.org
Circulation
|March 10, 2001
概括
在患有高胆固醇血症的患者中,瑞瓦斯塔丁在8周内显著降低了C-反应蛋白 (CRP) 水平. 这种CRP的减少独立于LDL胆固醇或HDL胆固醇水平的变化.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 众所周知,他类药物,包括cerivastatin,可以降低C反应蛋白 (CRP) 水平.
- 关于他类药物诱导的CRP降低的速度,概括性和剂量反应存在不确定性.
研究的目的:
- 为了研究雪里瓦斯塔丁对CRP水平的影响.
- 为了确定cerivastatin降低CRP是否依赖于剂量并与脂质变化相关.
主要方法:
- 一项涉及785名患有原发性高胆固醇血症的患者的研究.
- 在基线和8周后测量CRP,LDL胆固醇 (LDL-C) 和HDL胆固醇 (HDL-C).
- 用0.4毫克或0.8毫克的塞里瓦斯塔丁治疗.
主要成果:
- 瑞瓦斯塔丁显著降低了CRP中位数13.3%,平均CRP降低了24.5% (P<0.001).
- LDL-C因剂量而有所下降,但没有观察到CRP降低的明确剂量反应.
- 在CRP的变化和LDL-C或HDL-C的变化之间没有发现显著的相关性.
结论:
- 在患有原发性高胆固醇血症的患者中,切瑞瓦斯塔丁治疗在8周内有效降低了CRP水平.
- 观察到的CRP降低独立于降脂效应.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

